美国Affymetrix Panomics  www.panomics.com
2008年Affymetrix收购Panomics
Panomics Inc.是一家致力于平行定量生物学(PQB)领域的生命科学公司，位于美国硅谷。产品主要应用于细胞信号转导、RNA干扰调控的基因沉默、生物标志物的发现、预测毒理学和转录调控等研究领域，Panomics Inc.旨在成为生命科学研究、临床研究、药物发现等研究领域的领先者。 
Panomics公司的QuantiGene2.0 产品是基于Branched DNA（b-DNA）技术，完成核酸水平的精确定量检测。它克服了传统的real-time PCR（或者q-PCR）技术中的种种缺陷与不确定因素，无需抽提纯化RNA，无需反转录，无需PCR扩增，对样本量下限无要求（只需mRNA拷贝数在检测范围内），只需将样本用特定裂解液裂解后，经探针杂交与信号放大即可迅速得到比real-time PCR更加精确的定量结果。除组织、细胞样本外，该技术对血液样本与福尔马林浸泡、石蜡包埋切片（FFPE）同样具有极高的精确度、准确性与重现性。

 Affymetrix Completes Acquisition of Panomics
Panomics now part of Affymetrix, is still focused on delivering innovative solutions for Parallel Quantitative Biology or PQB.
What is PQB? We define PQB as contextual, systems-level measurements of genes, proteins and their cellular functions. PQB will facilitate understanding of biological pathways and networks in the context of normal physiology and development, disease pathology and drug treatment.
Our mission is to establish worldwide leadership with PQB products for basic life science research, clinical research, and drug discovery and development based on innovative solutions for critical applications such as cell signaling, RNAi-mediated gene silencing and high information assays, clinical biomarker discovery, predictive toxicology and transcription regulation.